Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antineoplastic Agents, Immunological”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Early research (Phase 1)Study completedNCT00000954
What this trial is testing

Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Ended earlyNCT04894994
What this trial is testing

FLX475 in Combination With Ipilimumab in Advanced Melanoma

Who this might be right for
Advanced Melanoma
RAPT Therapeutics, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00000801
What this trial is testing

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 33
Early research (Phase 1)Study completedNCT04728334
What this trial is testing

Dose Escalation and Expansion Study of AK117

Who this might be right for
Neoplasms Malignant
Akeso 49
Testing effectiveness (Phase 2)Study completedNCT03198689
What this trial is testing

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Large-scale testing (Phase 3)Active Not RecruitingNCT06790966
What this trial is testing

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+2 more
PDS Biotechnology Corp. 351
Not applicableStudy completedNCT00002226
What this trial is testing

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
SUGEN 30
Testing effectiveness (Phase 2)UnknownNCT06134193
What this trial is testing

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Who this might be right for
CarcinomaIntrahepatic CholangiocarcinomaGallbladder Cancer+5 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 41
Large-scale testing (Phase 3)Looking for participantsNCT05722886
What this trial is testing

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol

Who this might be right for
Haematological MalignancySolid Tumour
Cancer Research UK 825
Not applicableNot Yet RecruitingNCT07124858
What this trial is testing

Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)Antineoplastic Agents, ImmunologicalVEGFR-TKI
Federation Francophone de Cancerologie Digestive 300
Early research (Phase 1)Study completedNCT00028431
What this trial is testing

Novel Adjuvants for Peptide-Based Melanoma Vaccines

Who this might be right for
Melanoma
University of Southern California 19
Testing effectiveness (Phase 2)Study completedNCT00002189
What this trial is testing

Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals

Who this might be right for
Sarcoma, KaposiHIV Infections
Baker Norton Pharmaceuticals
Early research (Phase 1)Study completedNCT00002137
What this trial is testing

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4

Who this might be right for
Sarcoma, KaposiHIV Infections
Daiichi Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00002314
What this trial is testing

Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Hoffmann-La Roche
Testing effectiveness (Phase 2)Looking for participantsNCT05281003
What this trial is testing

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Testing effectiveness (Phase 2)Study completedNCT03349450
What this trial is testing

DPX-Survivac and Checkpoint Inhibitor in DLBCL

Who this might be right for
Adult Diffuse Large Cell LymphomaRecurrentAdult Refractory Diffuse Large B-Cell Lymphoma
Sunnybrook Health Sciences Centre 25
Early research (Phase 1)Study completedNCT00000763
What this trial is testing

A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT00002138
What this trial is testing

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.

Who this might be right for
Sarcoma, KaposiHIV Infections
Daiichi Pharmaceuticals
Load More Results